TGM2 and rheumatoid arthritis: The cell viability, EdU staining, and transwell assays displayed that TGM2 knockdown further inhibited the cell viability of MTX‐treated RA‐FLS and impaired proliferation, migration, and invasion of RA‐FLS (Figure 3F–J).